De Ying Cao
Directeur/Bestuurslid bij HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Profiel
De Ying Cao is an Independent Director at Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Hebei Yipin Pharmaceutical Co., Ltd., and a Professor at Hebei Medical University.
Cao's former position was as an Independent Director at Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Actieve functies van De Ying Cao
Bedrijven | Functie | Begin |
---|---|---|
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Directeur/Bestuurslid | 30-12-2021 |
Hebei Medical University | Corporate Officer/Principal | 08-08-2011 |
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Directeur/Bestuurslid | 01-05-2021 |
Eerdere bekende functies van De Ying Cao
Bedrijven | Functie | Einde |
---|---|---|
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |